Literature DB >> 24022166

The cardiorenal syndrome: what the cardiologist needs to know.

Bård Waldum1, Ingrid Os.   

Abstract

Interactions between the heart and the kidneys are increasingly acknowledged among both cardiologists and nephrologists. The term cardiorenal syndrome now applies to the bidirectional nature of how disease in one organ system affects the function of the other organ system. Cardiovascular disease is a major threat to patients with chronic kidney disease, while renal dysfunction is prevalent in patients with cardiac disease and is a significant predictor of prognosis in cardiac patients. Still, renal patients with cardiac disease have largely been excluded from the clinical trials that have been the basis of modern cardiologic treatment. In this review, the current understanding of the pathophysiological mechanisms involved in the cardiorenal syndrome and potential therapeutic implications will be summarized from a nephrologist's point of view. Probably, fragile cardiorenal patients will benefit from an enhanced collaboration between cardiologists and nephrologists to secure the best treatment given under safe conditions.
Copyright © 2013 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24022166     DOI: 10.1159/000353261

Source DB:  PubMed          Journal:  Cardiology        ISSN: 0008-6312            Impact factor:   1.869


  7 in total

Review 1.  Noncardiac comorbidities in heart failure with reduced versus preserved ejection fraction.

Authors:  Robert J Mentz; Jacob P Kelly; Thomas G von Lueder; Adriaan A Voors; Carolyn S P Lam; Martin R Cowie; Keld Kjeldsen; Ewa A Jankowska; Dan Atar; Javed Butler; Mona Fiuzat; Faiez Zannad; Bertram Pitt; Christopher M O'Connor
Journal:  J Am Coll Cardiol       Date:  2014-11-24       Impact factor: 24.094

Review 2.  Heart failure and kidney dysfunction: epidemiology, mechanisms and management.

Authors:  Joerg C Schefold; Gerasimos Filippatos; Gerd Hasenfuss; Stefan D Anker; Stephan von Haehling
Journal:  Nat Rev Nephrol       Date:  2016-08-30       Impact factor: 28.314

3.  Cross-sectional analysis of serum calcium levels for associations with left ventricular hypertrophy in normocalcemia individuals with type 2 diabetes.

Authors:  Junfeng Li; Nan Wu; Yintao Li; Kuanping Ye; Min He; Renming Hu
Journal:  Cardiovasc Diabetol       Date:  2015-04-29       Impact factor: 9.951

4.  Cardiac Troponin I and Amino-Terminal Pro B-Type Natriuretic Peptide in Dogs With Stable Chronic Kidney Disease.

Authors:  L Pelander; J Häggström; C J Ley; I Ljungvall
Journal:  J Vet Intern Med       Date:  2017-04-03       Impact factor: 3.333

5.  Apela improves cardiac and renal function in mice with acute myocardial infarction.

Authors:  Yang Pan; Quanyi Li; Hong Yan; Jin Huang; Zhi Wang
Journal:  J Cell Mol Med       Date:  2020-07-20       Impact factor: 5.310

6.  Renal and intraglomerular haemodynamics in chronic heart failure with preserved and reduced ejection fraction.

Authors:  Susanne Jung; Agnes Bosch; Julie Kolwelter; Kristina Striepe; Dennis Kannenkeril; Tizia Schuster; Christian Ott; Stephan Achenbach; Roland E Schmieder
Journal:  ESC Heart Fail       Date:  2021-02-09

7.  The impact of chronic kidney disease on the annual prognosis in patients 80+ years old suffering from chronic heart failure.

Authors:  Anna Cichocka-Radwan; Tomasz Ciurus; Malgorzata Lelonek
Journal:  Kardiochir Torakochirurgia Pol       Date:  2014-09-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.